These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8981930)

  • 1. Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells.
    Wing MG; Moreau T; Greenwood J; Smith RM; Hale G; Isaacs J; Waldmann H; Lachmann PJ; Compston A
    J Clin Invest; 1996 Dec; 98(12):2819-26. PubMed ID: 8981930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H.
    Zhang Z; Zhang M; Goldman CK; Ravetch JV; Waldmann TA
    Cancer Res; 2003 Oct; 63(19):6453-7. PubMed ID: 14559836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of natural killer cells by rabbit antithymocyte globulin and campath-1H: similar effects independent of specificity.
    Stauch D; Dernier A; Sarmiento Marchese E; Kunert K; Volk HD; Pratschke J; Kotsch K
    PLoS One; 2009; 4(3):e4709. PubMed ID: 19266059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex-vivo whole blood cultures for predicting cytokine-release syndrome: dependence on target antigen and antibody isotype.
    Wing MG; Waldmann H; Isaacs J; Compston DA; Hale G
    Ther Immunol; 1995 Aug; 2(4):183-90. PubMed ID: 9358610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FcγRIIIa-dependent IFN-γ release in whole blood assay is predictive of therapeutic IgG1 antibodies safety.
    Alakhras NS; Qiu J; Rocha GV; Witcher DR; Koester A; You J; Schaer DA; Holmgaard RB; Driscoll K; Willy JA; Malherbe LP
    MAbs; 2018; 10(6):913-921. PubMed ID: 29953319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of megakaryocytopoiesis by Campath-1G-treated natural killer cells.
    Nagler A; Condiotti R; Lubina A; Deutsch VR
    Bone Marrow Transplant; 1997 Oct; 20(7):525-31. PubMed ID: 9337053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coengagement of CD16 and CD94 receptors mediates secretion of chemokines and induces apoptotic death of naive natural killer cells.
    Jewett A; Cacalano NA; Head C; Teruel A
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1994-2003. PubMed ID: 16609008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of cloned human natural killer cells via Fc gamma RIII.
    Werfel T; Uciechowski P; Tetteroo PA; Kurrle R; Deicher H; Schmidt RE
    J Immunol; 1989 Feb; 142(4):1102-6. PubMed ID: 2464637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
    Gan X; Zhang L; Solomon GF; Bonavida B
    Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions.
    Kinder M; Greenplate AR; Strohl WR; Jordan RE; Brezski RJ
    MAbs; 2015; 7(3):494-504. PubMed ID: 25933349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
    Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
    Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17 beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages.
    Kramer PR; Kramer SF; Guan G
    Arthritis Rheum; 2004 Jun; 50(6):1967-75. PubMed ID: 15188374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling through the LFA-1 leucocyte integrin actively regulates intercellular adhesion and tumor necrosis factor-alpha production in natural killer cells.
    Melero I; Balboa MA; Alonso JL; Yagüe E; Pivel JP; Sanchez-Madrid F; López-Botet M
    Eur J Immunol; 1993 Aug; 23(8):1859-65. PubMed ID: 8344347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of Fc gamma receptor IIIA alpha (CD16-II) on natural killer cells induced by anti-CD16 mAb is independent of protein tyrosine kinases and protein kinase C.
    Borrego F; Lopez-Beltran A; Peña J; Solana R
    Cell Immunol; 1994 Oct; 158(1):208-17. PubMed ID: 8087866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CD16 (Fc receptor III) and interleukin-2 in the reactivation of natural killer cells after inhibitory target cell contact.
    Heiskala M; Ståhls A; Seppälä I; Timonen T
    Nat Immun Cell Growth Regul; 1991; 10(5):265-77. PubMed ID: 1836835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Human FcγR Gene Polymorphisms on IgG-Triggered Cytokine Release: Critical Importance of Cell Assay Format.
    Hussain K; Hargreaves CE; Rowley TF; Sopp JM; Latham KV; Bhatta P; Sherington J; Cutler RM; Humphreys DP; Glennie MJ; Strefford JC; Cragg MS
    Front Immunol; 2019; 10():390. PubMed ID: 30899264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-class II -DR humanized monoclonal antibody, IMMU-114, blocks allogeneic immune response.
    Park KH; Sawada T; Murakami T; Ishii Y; Yasuo M; Fuchinoue S; Goldenberg DM; Kubota K
    Am J Surg; 2012 Oct; 204(4):527-34. PubMed ID: 22658578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.
    Hadley AG; Zupanska B; Kumpel BM; Leader KA
    Immunology; 1992 Jul; 76(3):446-51. PubMed ID: 1356095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Campath-1G impairs human natural killer (NK) cell-mediated cytotoxicity.
    Condiotti R; Nagler A
    Bone Marrow Transplant; 1996 Oct; 18(4):713-20. PubMed ID: 8899185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fc gamma-receptor III (CD 16) is involved in NK-B cell interaction.
    Lenz P; Gessner JE; Sautes C; Schmidt RE
    Immunobiology; 1996; 196(4):387-98. PubMed ID: 9061379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.